Gujarat Kidney And Super Speciality Approves ₹107.80 Crore Acquisition Deal

2 min read     Updated on 06 Jan 2026, 07:15 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Gujarat Kidney And Super Speciality Limited's board approved two major healthcare acquisitions - purchasing the remaining 49% equity stake in Harmony Medicare Private Limited for ₹107.80 crores to make it a wholly owned subsidiary, and approving ₹124 crores payment for the previously acquired Ashwini Medical Centre. Both transactions are expected to complete within two months and align with the company's healthcare sector expansion strategy.

29252706

*this image is generated using AI for illustrative purposes only.

Gujarat Kidney And Super Speciality Limited announced significant expansion moves as its board of directors approved two major acquisitions during a meeting held on January 6, 2026. The healthcare company has decided to acquire the remaining 49% equity stake in Harmony Medicare Private Limited and make a substantial payment for its previously acquired Ashwini Medical Centre.

Harmony Medicare Acquisition Details

The board approved the purchase of the remaining 49% equity stake in Harmony Medicare Private Limited for ₹107.80 crores through cash consideration. This strategic acquisition will convert Harmony Medicare into a wholly owned subsidiary of Gujarat Kidney And Super Speciality Limited.

Parameter: Details
Acquisition Cost: ₹107.80 crores
Shareholding Acquired: 49% (4,90,000 equity shares)
Completion Timeline: 2 months (approximate)
Consideration Type: Cash

Harmony Medicare Private Limited, incorporated on June 16, 2009, operates as a medical and healthcare service provider with its registered office in Bharuch, Gujarat. The company has demonstrated consistent growth over the past three years.

Financial Year: Turnover
FY 2024-25: ₹422.86 crores
FY 2023-24: ₹360.46 crores
FY 2022-23: ₹277.02 crores

The target company maintains an authorized share capital of ₹10.00 crores and paid-up capital of ₹10.00 crores, comprising 10,00,000 equity shares of ₹10 each.

Ashwini Medical Centre Payment Approval

In accordance with the acquisition agreement and IPO objectives, the board approved a part payment of ₹124.00 crores as purchase consideration for the already acquired Ashwini Medical Centre. This partnership firm, established on April 22, 2004, in Anand, Gujarat, provides medical and pharmacy services.

Parameter: Details
Total Acquisition Cost: ₹140.00 crores
Amount Already Paid: ₹16.00 crores
Current Approval: ₹124.00 crores
Control Acquired: 100%

Ashwini Medical Centre has shown stable performance with the following turnover figures:

Financial Year: Turnover
FY 2024-25: ₹45.07 crores
FY 2023-24: ₹48.49 crores
FY 2022-23: ₹36.79 crores

Strategic Impact and Regulatory Compliance

Both acquisitions align with Gujarat Kidney And Super Speciality Limited's strategy to strengthen its presence in the healthcare sector and diversify its business portfolio. The Harmony Medicare acquisition represents a related party transaction conducted at arm's length, while the Ashwini Medical Centre acquisition does not involve related parties.

Neither acquisition requires governmental or regulatory approvals, and both transactions are expected to complete within approximately two months. The company has fulfilled all disclosure requirements under Regulation 30 of SEBI Listing Regulations, providing comprehensive details in the annexures to its board meeting outcome.

like19
dislike
Explore Other Articles